FDA status
FDA states that retatrutide is not a component of an FDA-approved drug and cannot be used in compounding under federal law.
FDA linkSource page tracker
Find Retatrutide listings and status.
A simple comparison of public listing claims, pricing, availability, warnings, and source links. Retatrutide is investigational; this page is for comparison purposes only and is not buying guidance. Non-USD prices are approximate USD conversions.
| Product | Location | Price | Availability | Use warning | Link |
|---|
Checked April 29, 2026
Official status sources
Lilly status
Lilly says retatrutide is investigational and not yet available for public use.
Lilly linkClinical trials
ClinicalTrials.gov lists retatrutide studies, including Phase 3 trials sponsored by Eli Lilly.
ClinicalTrials.gov linkGuides
Retatrutide research pages
FDA approval status
What official sources say about retatrutide approval and public availability.
Read status guideClinical trials
How to check current retatrutide studies and understand trial-only access.
Read trials guidePrice comparison
How the table handles public price claims and approximate USD conversions.
Read price guideOnline listing warnings
Why research-use labels and online listings need careful verification.
Read warning guideMethodology
How listings, images, prices, and warnings are collected and updated.
Read methodologyEditorial policy
The standards used for claims, corrections, source links, and health-sensitive text.
Read editorial policy